Skip to main content

Latest SEC Filings — Page 86

Page 86 · 30 filings scored 7+ · newest 6:00 AM ET · How scores work

Tue, Oct 203 filings
Mon, Oct 1927 filings
7SKKRantizoRantizo Holder Phillip Oldridge Discloses 9.02% Stake, Backs US Redomicile and Board ChangesSchedule 13D · Ownership stake● Neutral7COPLCopley Acquisition CorpCopley Sets Oct 29 Vote on 12-Month Extension After Ignite Deal CollapseDEF 14A · Proxy● Neutral8CABOCable One, Inc.Graham Trusts Complete Exit: Cable One Insider Sells Below 5% as Stock CratersSchedule 13D/A · Ownership stake▼ NegativePro8BCABBioAtla, Inc.BioAtla Registers 8.18M Shares for New $40M Yorkville Standby Equity FacilityForm S-1 · Offering▼ NegativePro8NIMUNon-Invasive Monitoring Systems, Inc.NIMU Halves Gravitics IPO to $50M From $125M, Sets $14-$17/Share RangeForm S-1/A · Offering● NeutralPro8NIMUNon-Invasive Monitoring Systems, Inc.NIMU S-4/A No. 7: Gravitics Merger Terms Finalized, Offering Floor Cut to $40MForm S-4/A● NeutralPro8BCABBioAtla, Inc.BioAtla Signs $40M Yorkville Equity Line, Replacing $15M SEPAForm 8-K · Current report▼ NegativePro8INVInnventure, Inc.Activist Ascent Capital Hits 10.7% of Innventure, Demands NAV Floor on $60M ATMSchedule 13D/A · Ownership stake▲ PositivePro7TALOTalos Energy Inc.Slim Family's Control Empresarial Sells $47.3M of Talos Stock, Stake Down to 16.0%Form 4 · Insider trade▼ Negative9SLGNSilgan Holdings Inc.Silgan Files Definitive Trivium Deal: $1.025B AIP Partner, $4.9B MetalCo Debt, 60/40 VentureForm 8-K · Current report▲ PositivePro8IAMIambic Therapeutics, Inc.Director Buys $11.5M of Iambic Stock at IPO Price; Preferred Converts to CommonForm 4 · Insider trade▲ PositivePro8TVATexas Ventures Acquisition III CorpTVA Shareholders Approve Extension to July 2027; 78.66% of Class A Shares Redeem for ~$187MForm 8-K · Current report▼ NegativePro8IRONDisc Medicine, Inc.Disc Medicine Files $350M Offering Terms After APOLLO Phase 3 WinForm 424B5 · Offering▼ NegativePro8SNESSenesTech, Inc.Glenbrook Buys $706K More SenesTech Stock, Lifting Stake Toward 38%Form 4 · Insider trade▲ PositivePro7CTYCity Therapeutics, Inc.Director Robert Nelsen Buys $3.06M of City Therapeutics at $18 IPO PriceForm 4 · Insider trade▲ Positive8SNESSenesTech, Inc.Glenbrook Doubles SenesTech Stake to 38%, Launches Activist Push on Board and Capital DisciplineSchedule 13D/A · Ownership stake▲ PositivePro7AEROGrupo Aeromexico, S.A.B. de C.V.Aeroméxico Posts Record $1.6B 3Q26 Revenue but Profit Falls 58% on Fuel CostsForm 6-K · Current report▼ Negative7AEROGrupo Aeromexico, S.A.B. de C.V.U.S. DOT Lifts Mexico-U.S. Schedule Restrictions on AeromexicoForm 6-K · Current report▲ Positive7CMMBChemomab Therapeutics Ltd.Chemomab Halves Combined-Company Share Count to 5M in Merger Amendment No. 2Form 6-K · Current report● Neutral8CHRDChord Energy CorpChord Swaps CEO and Pre-Announces Strong 3Q26 With $550MM Marcellus SaleForm 8-K · Current report● NeutralPro8STRRStar Equity Holdings, Inc.Star Equity Files S-4 for $38M Harte Hanks Merger, Quantifies $19.2M Cash CapForm S-4● NeutralPro7AIAIAIAI Holdings CorpAIAI Registers 14.9M Shares for Resale Under B. Riley $200M Equity LineForm S-1 · Offering▼ Negative7ISPCiSpecimen Inc.iSpecimen Cuts Reverse-Split Approval Threshold, Adjourns Vote to October 30DEFR14A · Proxy▼ Negative9DPUNexpu Ltd.Nexpu Closes $28M Regulation S Unit Placement at $0.70, Roughly Half Today's PriceForm 6-K · Current report▼ NegativePro8RMCFRocky Mountain Chocolate Factory, Inc.RMCF Q2 Loss Widens to $1.3M; Going Concern Reiterated, Covenants in DefaultForm 10-Q · Periodic report▼ NegativePro7UMHUMH Properties, Inc.Erez Escalates UMH Fight, Alleges $65M Lost to Four REIT BankruptciesDFAN14A · Proxy▼ Negative7AISPAirship AI Holdings, Inc.Airship AI Seeks Nevada Reincorporation, Unilateral Reverse-Split AuthorityPRE 14A · Proxy▼ Negative
How Wiseek picks and scores these

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.